The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans
Abstract
Involvement of the NMDA receptor system in the transmission of nociceptive information, including the development of central sensitization and a wind-up phenomenon, has increased interest in NMDA-receptor antagonists as antinociceptive drugs. This case report describes the use of an NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in a carefully selected patient with severe and intractable neurogenic pain in her left leg. The pain syndrome had components of a continuous deep pain, an allodynia, and a wind-up-like component, including afterdischarge and spread of painful sensations outside the territory of the injured nerve. After intrathecal (i.t.) administration of 200 nmol of CPP the continuous deep pain component and allodynia were unchanged, but the following 'wind-up' phenomenon with afterdischarge and spread of the pain sensation in the left half of the body was completely abolished. Another 500 nmol of CPP administered over 2 h did not improve pain relief. Pain thresholds for heat and cold stimulation, measured with a Marstock thermostimulator, did not change. There was no effect on blood pressure, heart rate, sensitivity, reflexes, coordination or motor performance. Psychotomimetic ketamine-like side effects developed 4 h after the last injection of CPP and were probably due to rostral spread of CPP. These early experiences with i.t. administration of NMDA-receptor antagonists to humans indicate that the NMDA-receptor system plays an important role in neurogenic pain and that antagonizing this system may be a useful way to obtain better pain control although psychotomimetic side effects due to rostral spread may be a problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Woolf, C. J., & Thompson, S. W. N. (1991) · Pain · doi:10.1016/0304-3959(91)90100-c · Cited by 1,963
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Arnér, S., & Meyerson, B. A. (1988) · Pain · doi:10.1016/0304-3959(88)90198-4 · Cited by 991
Measurement of local cerebral blood flow with iodo [14C] antipyrine
Sakurada, O., Kennedy, C., Jehle, J., Brown, J. D., Carbin, G. L., & Sokoloff, L. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.234.1.h59 · Cited by 926
Physiological properties of unmyelinated fiber projection to the spinal cord
Mendell, L. M. (1966) · Experimental Neurology · doi:10.1016/0014-4886(66)90068-9 · Cited by 845
Dickenson, A. H., & Sullivan, A. F. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90275-9 · Cited by 843
Method for quantitative estimation of thermal thresholds in patients.
Fruhstorfer, H., Lindblom, U., & Schmidt, W. C. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.11.1071 · Cited by 781
Davies, S. N., & Lodge, D. (1987) · Brain Research · doi:10.1016/0006-8993(87)91487-9 · Cited by 663
Skilling, S. R., Smullin, D. H., Beitz, A. J., & Larson, A. A. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04845.x · Cited by 386
RECENT ADVANCES IN THE PATHOPHYSIOLOGY OF ACUTE PAIN
WOOLF, C. J. (1989) · British Journal of Anaesthesia · doi:10.1093/bja/63.2.139 · Cited by 376
Aanonsen, L. M., & Wilcox, G. L. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39258-x · Cited by 375
Cited by
Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993) · Pain · doi:10.1016/0304-3959(93)90161-h · Cited by 1,966
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Glutamate as a neurotransmitter in the brain: review of physiology and pathology
Meldrum, B. S. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1007s · Cited by 1,667
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Wind-up of spinal cord neurones and pain sensation: much ado about something?
Herrero, J. F., Laird, J. M. A., & Lopez-Garcia, J. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00051-9 · Cited by 714
D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia
Tsai, G. E., Yang, P., Chang, Y.-C., & Chong, M.-Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 674
Danysz, W., & Parsons, C. G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01382-6 · Cited by 649
D-serine added to antipsychotics for the treatment of schizophrenia
Tsai, G., Yang, P., Chung, L.-C., Lange, N., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 571
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
Bräuner-Osborne, H., Egebjerg, J., Nielsen, E. Ø., Madsen, U., & Krogsgaard-Larsen, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000007r · Cited by 524
Clinical Experience With Excitatory Amino Acid Antagonist Drugs
Muir, K. W., & Lees, K. R. (1995) · Stroke · doi:10.1161/01.str.26.3.503 · Cited by 502
Eide, P. K., Jørum, E., Stubhaug, A., Bremnes, J., & Breivik, H. (1994) · Pain · doi:10.1016/0304-3959(94)90129-5 · Cited by 490
Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients
Graven-Nielsen, T., Kendall, S. A., Henriksson, K. G., Bengtsson, M., Sörensen, J., Johnson, A., Gerdle, B., & Arendt-Nielsen, L. (2000) · Pain · doi:10.1016/s0304-3959(99)00308-5 · Cited by 416
Chaplan, S. R., Malmberg, A. B., & Yaksh, T. L. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36427-4 · Cited by 372
Schwartzman, R. J., Alexander, G. M., Grothusen, J. R., Paylor, T., Reichenberger, E., & Perreault, M. (2009) · Pain · doi:10.1016/j.pain.2009.08.015 · Cited by 357
Tsai, G., Lane, H.-Y., Yang, P., Chong, M.-Y., & Lange, N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.012 · Cited by 342
Boyce, S., Wyatt, A., Webb, J. K., O’Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R. G., & Rupniak, N. M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00218-4 · Cited by 342
Wind‐up and the NMDA receptor complex from a clinical perspective
Eide, P. K. (2000) · European Journal of Pain · doi:10.1053/eujp.1999.0154 · Cited by 332
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study
Backonja, M., Arndt, G., Gombar, K. A., Check, B., & Zimmermann, M. (1994) · Pain · doi:10.1016/0304-3959(94)90149-x · Cited by 312
NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride
Felsby, S., Nielsen, J., Arendt-Nielsen, L., & Jensen, T. S. (1996) · Pain · doi:10.1016/0304-3959(95)00113-1 · Cited by 289
Central hyperexcitability triggered by noxious inputs
McMahon, S. B., Lewin, G. R., & Wall, P. D. (1993) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(93)90062-4 · Cited by 288
Arendt-Nielsen, L., Petersen-Felix, S., Fischer, M., Bak, P., Bjerring, P., & Zbinden, A. M. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199507000-00013 · Cited by 272
Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management
Fisher, K., Coderre, T. J., & Hagen, N. A. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00213-x · Cited by 266
Modulation and Block of Ion Channels: A New Biology of Polyamines
Williams, K. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(96)00089-7 · Cited by 264
Non-steroidal anti-inflammatory drugs and spinal nociceptive processing
McCormack, K. (1994) · Pain · doi:10.1016/0304-3959(94)90045-0 · Cited by 263
Vierck, C. J., Cannon, R. L., Fry, G., Maixner, W., & Whitsel, B. L. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.2.992 · Cited by 258
Sang, C. N., Booher, S., Gilron, I., Parada, S., & Max, M. B. (2002) · Anesthesiology · doi:10.1097/00000542-200205000-00005 · Cited by 254
The spinal biology in humans and animals of pain states generated by persistent small afferent input
Yaksh, T. L., Hua, X.-Y., Kalcheva, I., Nozaki-Taguchi, N., & Marsala, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7680 · Cited by 252
Glutamate Receptors and Nociception: Implications for the Drug Treatment of Pain
Fundytus, M. E. (2001) · CNS Drugs · doi:10.2165/00023210-200115010-00004 · Cited by 250
Walters, E. T. (1994) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60307-4 · Cited by 206
Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception
McNearney, T. A., & Westlund, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713196 · Cited by 9
Metadata
- Authors
- Kristensen, J. D., Svensson, B., & Gordh, T.
- Venue
- Pain
- Published
- 1992-11
- Volume
- 51
- Issue
- 2
- Pages
- 249-253
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2067354763
- Cited by
- 301
- References
- 15
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.